Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR
J Eur Acad Dermatol Venereol
.
2021 Aug;35(8):e498-e501.
doi: 10.1111/jdv.17230.
Epub 2021 Mar 29.
Authors
K J Mason
1
2
,
A D Burden
3
,
J N W N Barker
4
,
M Lunt
1
,
H Ali
1
,
C E Kleyn
1
5
,
K McElhone
1
,
M M Soliman
6
,
A C Green
1
7
8
,
C E M Griffiths
1
5
,
N J Reynolds
9
10
,
A D Ormerod
11
;
BADBIR Study Group
12
Collaborators
BADBIR Study Group
:
Fiona Browne
,
Ian Evans
,
Brian Kirby
,
Linda Lawson
,
Philip Laws
,
Teena Mackenzie
,
Tess McPherson
,
Ruth Murphy
,
Caroline Owen
,
Eleanor Pearson
,
Josh Richards
,
Catherine Smith
,
Richard Warren
,
Gabrielle Belcher
,
Anthony Bewley
,
Simon Morrison
Affiliations
1
Division of Musculoskeletal and Dermatological Sciences, NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, UK.
2
School of Medicine, Keele University, Staffordshire, UK.
3
Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
4
St John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
5
The Dermatology Centre, Salford Royal NHS Foundation Trust, Salford, UK.
6
Department of Pharmacy Practice, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
7
QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
8
Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK.
9
Institute of Translation and Clinical Medicine, Newcastle University, Newcastle upon Tyne, UK.
10
Newcastle Dermatology, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK.
11
Division of Applied Medicine, Aberdeen University, Aberdeen, UK.
12
British Association of Dermatologists, London, UK.
PMID:
33725378
DOI:
10.1111/jdv.17230
No abstract available
Publication types
Letter
MeSH terms
Humans
Psoriasis* / complications
Psoriasis* / epidemiology
Skin Neoplasms* / epidemiology
Ustekinumab
Substances
Ustekinumab
Grants and funding
AbbVie
Almirall
Amgen
Celgene
Janssen
LEO Pharma
Lilly
Novartis
Samsung Bioepis
Sandoz Hexal AG
UCB Pharma
Manchester NIHR Biomedical Research Centre
Department of Health via the NIHR BioResource Clinical Research Facility
Newcastle NIHR Medtech and In vitro diagnostic Co-operative